π Ponaxen 15 mg Tablets
(Ponatinib Hydrochloride INN)
A Potent Oral Therapy for Resistant Leukemia
π Product Summary:
-
Brand Name: Ponaxen
-
Generic Name: Ponatinib Hydrochloride INN
-
Strength: 15 mg
-
Form: Film-coated tablets
-
Packaging: Bottle of 30 tablets
-
Manufacturer: Everest Pharmaceuticals Ltd.
-
Marketed by: NP Molecule
𧬠What is Ponaxen (Ponatinib)?
Ponaxen contains Ponatinib, a powerful third-generation tyrosine kinase inhibitor (TKI) used in the treatment of specific types of leukemia. It is uniquely designed to target and inhibit BCR-ABL fusion protein, including those with the T315I mutation β a mutation resistant to most other TKIs.
β
Indications:
Ponaxen is indicated for the treatment of:
βοΈ Chronic Myeloid Leukemia (CML) β Chronic, Accelerated, or Blast Phase
βοΈ Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL)
βοΈ Particularly effective in patients with the T315I mutation or who are resistant or intolerant to previous TKIs
π Dosage & Administration:
-
Recommended starting dose: 15 mg orally once daily
-
Can be taken with or without food
-
Dose adjustments may be required based on individual response and side effects
-
Regular monitoring of blood counts, liver function, and cardiovascular health is advised
βοΈ Mechanism of Action:
Ponatinib works by inhibiting BCR-ABL kinase, including mutated forms such as T315I, and other kinases involved in cancer progression. It effectively blocks cancer cell signaling, proliferation, and survival.
β οΈ Potential Side Effects:
Common adverse effects may include:
π¨ Black Box Warning: Ponatinib carries risks of arterial occlusion, venous thrombosis, and hepatotoxicity. Use under strict medical supervision.
π§ Storage:
-
Store below 30Β°C in a dry place
-
Keep away from moisture and direct sunlight
-
Keep out of reach of children
π₯ Manufactured by:
Everest Pharmaceuticals Ltd. β WHO-GMP Compliant, Quality-Certified
π¦ Exclusively Marketed by:
π¬ NP Molecule β Oncology Expertise You Can Trust
π Sector-14, Uttara, Dhaka β 1230
π +8801844288466
π§ npmolecule23@gmail.com
π www.npmoleculeoncology.com
π± Scan the QR code for inquiries or bulk orders
π― Ponaxen β Targeting Leukemia with Precision
Fighting Resistance. Redefining Outcomes.